| Literature DB >> 27521855 |
Abstract
Entities:
Year: 2016 PMID: 27521855 PMCID: PMC4997905 DOI: 10.1016/j.bjhh.2016.05.012
Source DB: PubMed Journal: Rev Bras Hematol Hemoter ISSN: 1516-8484
Hematological features of some sickle hemoglobinopathies.
| Genotype | PCV (%) | Retic (%) | MCV (fL) | Hb F (%) | Hb A2 (%) | % Variant | Severity |
|---|---|---|---|---|---|---|---|
| SCA | 25 | 8 | 90 | 5 | 3 | >90% Hb S | ++++ |
| Hb SC disease | 35 | 3 | 80 | 2 | 3 | 50% Hb S, 50% Hb C | ++ |
| S-β0 thalassemia | 27 | 7 | 82 | 7 | 5 | 90% Hb S | ++++ |
| S-β+ thalassemia | 38 | 2 | 70 | 2 | 6 | 5–30% Hb A | ++ |
| SCA-α thalassemia | 30 | 6 | 78 | 5 | 5 | >90% Hb S | +++ |
| Hb SE disease | 35 | 3 | 75 | 2 | 3 | ∼30% Hb E | ++ |
| Hb SD disease* | 20 | 86 | 1–10 | 2–4 | 45% Hb S, 45% Hb D | +++ | |
| Sickle cell trait | 45 | 1 | 85 | 1 | 2 | 60% Hb A, 40% Hb S |
SCA: sickle cell anemia; PCV: packed cell volume; Retic: reticulocyte count; MCV: mean cell volume; Hb: Hemoglobin.
Severity of disease rated from most severe (++++) to absence of clinical events () includes complications related to sickle vaso-occlusion and hemolysis.
Table modified from 1 with * data obtained from 21, 27, 32.